This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Eisai R&D Management Co., Ltd., Merck Sharp & Dohme LLC, Msd International Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 13 
1 out of 70 
1 out of 9 Years Active: 2026
Title: Yasuhiro Funahashi: Cancer-Treatment Patent
Introduction
Yasuhiro Funahashi is an inventor associated with Tsukuba, Japan. His listed patent concerns a combination of targeted therapies for treating cancer.
Latest Patents
Funahashi is associated with 1 patent: “Combination of a PD-1 Antagonist, a VEGFR/FGFR/RET Tyrosine Kinase Inhibitor and a CBP/Beta-Catenin Inhibitor for Treating Cancer.” The patent describes combining a PD-1 antagonist, a tyrosine kinase inhibitor, and a CBP/beta-catenin inhibitor as a potential cancer-treatment approach.
Career Highlights
The available information lists Merck Sharp & Dohme LLC and MSD International GmbH among the companies with which Funahashi has been associated. His patent reflects work in pharmaceutical research and cancer therapeutics.
Collaborations
Funahashi’s listed coworkers include Yoichi Ozawa and Yu Kato.
Conclusion
Yasuhiro Funahashi’s recorded patent and professional associations connect his inventive work with research into combination therapies for cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile